Pharmaceutical Executive
The case of Amgen v. Sandoz signals that preliminary injunctions will play major role in future patent disputes
William Raich
Advertisement
Articles by William Raich
Advertisement
Latest Updated Articles
Biosimilar Litigation: Lessons So FarAugust 5th 2015
Advertisement
Advertisement
Trending on PharmExec
1
Viatris Acquires Pacira BioSciences for $1.65 Billion
2
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
3
ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care
4
Before You Sign with a New Hub Vendor, Ask These Four Questions
5